Sullivan Christopher Ryan sold AVTX
December 10, 2025 · Form 4 insider transaction
Sullivan Christopher Ryan sold 155 shares of Avalo Therapeutics, Inc. at $4.10 per share, a transaction worth $635.50. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
155
Price
$4.10
Total value
$635.50
InsiderSullivan Christopher Ryan
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateDecember 10, 2025
Filing dateDecember 12, 2025
Shares owned after17,338
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 417 additional shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as a part of this reporting transaction.